Jean-Yves Blay is Professor and Head of Medical Oncology at the Université Claude Bernard Lyon 1, France, and Head of the Translational Research Pole at Centre Léon Bérard in Lyon, France. He serves as Project Director for EUROSARC, and as President of the French Sarcoma Group. Professor Blay is also Head of the Reference Network for Sarcoma in France, a faculty member of the ESMO Sarcoma group, and a board member of the French Society of Cancer. His research interests focus on clinical and basic research in sarcomas, the biology of breast carcinoma, and the relation between tumour microenvironment and malignant cells. He has published over 400 peer-reviewed articles.
Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.
Angelo Paolo Dei Tos is Director of both the Department of Oncology and the Department of Pathology at the General Hospital of Treviso, Italy, and Consultant Pathologist at the Istituto Ortopedico Rizzoli in Bologna. He serves on numerous European and International boards and committees, including the WHO Working Group for the Classification of Tumours of Soft Tissue and Bone, ESMO and EORTC. Dr Dei Tos is a member of the editorial boards of several scientific journals and has published more than 180 peer-reviewed articles. His main clinical interest is focused on the morphologic and molecular diagnosis of sarcoma.
Alexander Fedenko is Chief of Sarcoma Services at the N.N. Blokhin Russian Cancer Research Centre and the Russian Academy of Medical Sciences, Moscow, Russia. He is also Executive Director of the East European Sarcoma Group. After completing his MD from the Moscow Medical Academy he undertook clinical residency in medical oncology at the Russian Cancer Research Centre. Professor Fedenko was awarded a PhD in oncoimmunology in 2006 from the Institute of Immunology in Moscow. He undertook further international training in sarcoma medical oncology, first at the USC Norris Cancer Center in California and later at the Anderson Cancer Center in Texas, USA. He has authored or co-authored over 50 publications.
Rick L.M. Haas was trained in radiotherapy by Professor Dr Bartelink at the Netherlands Cancer Institute in Amsterdam, where he still works as a staff member. His current research interests focus mainly on sarcomas where he has initiated several clinical phase I, II and III trials. He has authored or co-authored numerous papers on sarcoma.
Akira Kawai is Head of Musculoskeletal Oncology and Rehabilitation Medicine at the National Cancer Center Hospital (NCCH), Tokyo, Japan. He graduated from Okayama University Medical School and received a PhD for his thesis: ‘A newly established human osteosarcoma cell line with osteoblastic properties’. Akira Kawai was awarded a fellowship at the Memorial Sloan-Kettering Cancer Center New York, USA between 1996 and 1998, and transferred to the NCCH in 2002. Dr Kawai is an active member of ASCO, CTOS, SICOT, the Japanese Cancer Association and the Japanese Orthopaedic Association. He has served as Director of the Bone and Soft Tissue Tumour Registry in Japan.
Zsuzsanna Pápai graduated from the Semmelweis University of Budapest, Hungary. She has worked as an Assistant Professor of Clinical Oncology at the National Institute of Oncology in Budapest and as Head of the Oncology Department at the State Health Centre, before becoming Professor of Medical Oncology in 2012. Her main field of research is soft tissue and bone sarcomas. Professor Pápai has been a research fellow at the Medical University of Vienna, Austria, and at the National Cancer Institute, Washington DC, USA. She has authored nearly 200 publications and book chapters on oncology and enteral and parenteral nutrition.
Piotr Rutkowski graduated from the Medical University of Łódź, Poland, before specialising in surgical oncology. He was promoted to Associate Professor of the Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Poland, in 2008 and to full Professor of Surgical Oncology in 2013, where he heads the Department of Soft Tissue/Bone Sarcoma and Melanoma. Professor Rutkowski is a reviewer for several scientific journals and a member of numerous Polish and international scientific societies, including EORTC Soft Tissue and Bone Sarcoma Group. He has authored or co-authored over 90 scientific papers, including national and international recommendations in sarcoma and melanoma.
Daniel Vanel is Head of Research for the imaging of musculoskeletal tumours at the Rizzoli Institute in Bologna, Italy. He was formerly Chairman of radiology with the Gustave Roussy Institute in Villejuif, France. Professor Vanel is also past President of the European Society of Skeletal Radiology and International Cancer Imaging Society. He has authored or co-authored numerous clinical papers and book chapters and serves on several editorial boards, including Clinical Sarcoma Research and has been awarded the prestigious gold medal from the International Skeletal Society for his services.